The most frequent complication of mumps in males who have reached puberty is orchitis. Although there is a connection between mumps and pancreatitis (represented by the ‘M’ in GET SMASHED), this occurrence is not as prevalent as orchitis.

Understanding Mumps: Causes, Symptoms, Prevention, and Management

Mumps is a viral infection caused by RNA paramyxovirus that typically occurs during the winter and spring seasons. The virus spreads through droplets and affects respiratory tract epithelial cells, parotid glands, and other tissues. The infection is contagious, and a person can be infectious seven days before and nine days after the onset of parotid swelling. The incubation period for mumps is usually 14-21 days.

The clinical features of mumps include fever, malaise, and muscular pain. The most common symptom is parotitis, which causes earache and pain while eating. Initially, the swelling is unilateral, but it becomes bilateral in around 70% of cases.

Prevention of mumps is possible through the MMR vaccine, which has an efficacy rate of around 80%. Management of mumps involves rest and the use of paracetamol to alleviate high fever and discomfort. Mumps is a notifiable disease, and healthcare professionals must report cases to the relevant authorities.

Complications of mumps include orchitis, which is uncommon in pre-pubertal males but occurs in around 25-35% of post-pubertal males. It typically occurs four or five days after the onset of parotitis. Other complications include hearing loss, meningoencephalitis, and pancreatitis.

In conclusion, understanding the causes, symptoms, prevention, and management of mumps is crucial in preventing the spread of the infection and minimizing its complications. Vaccination and early diagnosis are essential in controlling the disease.

Despite his current treatment, he continues to experience episodes of hypoglycaemia due to receiving insulin twice a day. Transitioning to a basal bolus regimen would allow for the separation of the short-acting component of his insulin needs, thereby decreasing the likelihood of hypoglycaemia at the end of each dosing period.

Lowering the dosage of his mixed insulin or metformin may result in a further increase in his HbA1c levels. Switching to Humalog mix 20 would increase the amount of long-acting insulin and heighten the risk of hypoglycaemia. Consuming a snack would lead to weight gain and exacerbate his HbA1c levels.

Insulin therapy can have side-effects that patients should be aware of. One of the most common side-effects is hypoglycaemia, which can cause sweating, anxiety, blurred vision, confusion, and aggression. Patients should be taught to recognize these symptoms and take 10-20g of a short-acting carbohydrate, such as a glass of Lucozade or non-diet drink, three or more glucose tablets, or glucose gel. It is also important for every person treated with insulin to have a glucagon kit for emergencies where the patient is not able to orally ingest a short-acting carbohydrate. Patients who have frequent hypoglycaemic episodes may develop reduced awareness, and beta-blockers can further reduce hypoglycaemic awareness.

Another potential side-effect of insulin therapy is lipodystrophy, which typically presents as atrophy or lumps of subcutaneous fat. This can be prevented by rotating the injection site, as using the same site repeatedly can cause erratic insulin absorption. It is important for patients to be aware of these potential side-effects and to discuss any concerns with their healthcare provider. By monitoring their blood sugar levels and following their treatment plan, patients can manage the risks associated with insulin therapy and maintain good health.

For life-threatening cyanide overdose, the recommended IV therapy in the UK is intravenous dicobalt edetate. This is the most likely diagnosis after exposure in a house fire. If left untreated, it can lead to fatal consequences and is associated with significant metabolic acidosis, with a marked elevation in serum lactate. Therefore, timely intervention is crucial. In the acute setting, hydroxycobalamin may also be used.

In cases where IV access cannot be rapidly obtained, amyl nitrate can be considered as an inhaled antidote for cyanide poisoning. Additionally, alpha/beta adrenergic agonists may be used instead of anticholinergics as an additional intervention. DMSA is used to treat lead toxicity, while vitamin C is used to treat methaemoglobinaemia.

Understanding Cyanide Poisoning

Cyanide is a toxic substance that can be found in insecticides, photograph development, and metal production. When ingested, cyanide can inhibit the enzyme cytochrome c oxidase, which can lead to the cessation of the mitochondrial electron transfer chain. This can result in a range of symptoms, depending on the severity and duration of exposure.

The presentation of cyanide poisoning can vary, but some classical features include brick-red skin and a smell of bitter almonds. Acute symptoms may include hypoxia, hypotension, headache, and confusion. Chronic exposure can lead to ataxia, peripheral neuropathy, and dermatitis.

If someone is suspected of cyanide poisoning, supportive measures such as administering 100% oxygen should be taken immediately. Definitive treatment involves the use of hydroxocobalamin, which is given intravenously. A combination of inhaled amyl nitrite, intravenous sodium nitrite, and intravenous sodium thiosulfate may also be used.

It is important to seek medical attention immediately if cyanide poisoning is suspected, as prompt treatment can be life-saving.

The rash’s distribution indicates phototoxicity, which is only associated with amiodarone and flecainide among the listed medications. However, it should be noted that flecainide is not recommended for patients with a history of myocardial infarction.

Amiodarone and Thyroid Dysfunction

Amiodarone, a medication used to treat heart rhythm disorders, can cause thyroid dysfunction in approximately 1 in 6 patients. This dysfunction can manifest as either hypothyroidism or thyrotoxicosis.

Amiodarone-induced hypothyroidism (AIH) is believed to occur due to the high iodine content of the medication, which can cause a Wolff-Chaikoff effect. Despite this, amiodarone may still be continued if desired.

On the other hand, amiodarone-induced thyrotoxicosis (AIT) can be divided into two types: type 1 and type 2. Type 1 AIT is caused by excess iodine-induced thyroid hormone synthesis, while type 2 AIT is related to destructive thyroiditis caused by amiodarone. In patients with type 1 AIT, a goitre may be present, while it is absent in type 2 AIT. Management of AIT involves carbimazole or potassium perchlorate for type 1 and corticosteroids for type 2.

It is important to note that unlike in AIH, amiodarone should be stopped if possible in patients who develop AIT. Understanding the potential effects of amiodarone on the thyroid gland is crucial in managing patients who require this medication for their heart condition.

The most appropriate diagnostic test for pulmonary arterial hypertension in a middle-aged person with worsening shortness of breath, clear lung fields, and a diastolic murmur, along with an enlarged proximal pulmonary artery on chest X-ray, is right heart catheterisation. Although an ECG or echocardiogram may indicate pulmonary arterial hypertension, right heart catheterisation is the most reliable and accurate diagnostic tool.

Understanding Pulmonary Hypertension: Causes and Classification

Pulmonary hypertension is a condition characterized by a sustained increase in mean pulmonary arterial pressure of more than 25 mmHg at rest. Recently, the World Health Organization (WHO) has reclassified pulmonary hypertension into five groups based on their causes.

Group 1, also known as pulmonary arterial hypertension (PAH), includes idiopathic and familial cases, as well as those associated with collagen vascular disease, congenital heart disease with systemic to pulmonary shunts, HIV, drugs and toxins, and sickle cell disease. Persistent pulmonary hypertension of the newborn is also classified under this group.

Group 2 is pulmonary hypertension with left heart disease, which is caused by left-sided atrial, ventricular, or valvular disease such as left ventricular systolic and diastolic dysfunction, mitral stenosis, and mitral regurgitation.

Group 3 is pulmonary hypertension secondary to lung disease/hypoxia, which includes conditions such as COPD, interstitial lung disease, sleep apnea, and high altitude.

Group 4 is pulmonary hypertension due to thromboembolic disease, which is caused by blood clots in the lungs.

Finally, Group 5 is a miscellaneous category that includes conditions such as lymphangiomatosis, which can be secondary to carcinomatosis or sarcoidosis.

Understanding the classification of pulmonary hypertension is crucial in determining the appropriate treatment and management of the condition. By identifying the underlying cause, healthcare professionals can provide targeted interventions to improve the patient’s quality of life and prevent further complications.

Genetic Disorders and Andropause

Gaucher’s and Marfan syndrome are genetic disorders that do not cause infertility. Noonan’s syndrome, on the other hand, is associated with short stature. Klinefelter’s syndrome is a sex chromosome disorder that affects males, with a prevalence of 1 in 400 to 1 in 600 births. This disorder is characterized by the presence of an extra X chromosome, resulting in a karyotype of 47 XXY, XXXYY, or XXYY.

Andropause is a term used to describe the gradual decrease in serum testosterone concentration that occurs with age. However, this condition typically does not occur until after the age of 50. It is important to note that while these conditions may have some similarities, they are distinct and require different approaches to diagnosis and treatment. Proper diagnosis and management of these conditions can help individuals lead healthy and fulfilling lives.

Oculogyric Crisis and Pharmaceutical Agents

Oculogyric crisis is an acute dystonic reaction caused by dopaminergic blockade at the basal ganglia. It is commonly seen in young women and can be triggered by certain pharmaceutical agents such as metoclopramide. The treatment involves withdrawal of the drug and administration of antimuscarinic drugs like procyclidine hydrochloride or trihexyphenidyl hydrochloride (benzhexol). These drugs are also used in the treatment of parkinsonism. However, metoclopramide and prochlorperazine are not recommended for young women due to the risk of acute dystonia. Instead, other options like cyclizine or domperidone are preferred. Olanzapine is a first-line atypical antipsychotic agent used for schizophrenia, while clozapine is used for resistant psychosis. Although reports of oculogyric crisis exist for domperidone, it is not a treatment for this condition.

Management of Alcoholic Cardiomyopathy

Alcoholic cardiomyopathy is a condition that results from long-term alcohol abuse and can lead to heart failure. The primary intervention for this condition is complete and persistent abstinence from alcohol. While the volume overload status could indicate either cardiomyopathy or decompensated liver disease, the presence of basal crepitations increases the likelihood of a diagnosis of alcoholic cardiomyopathy.

Coronary artery stenting is not a suitable treatment for alcoholic cardiomyopathy as it causes regional abnormalities in the heart rather than global dilatation of the heart. Carvedilol has been associated with improved ejection fraction, but its use before abstinence from alcohol does not result in significant benefits.

The sacubitril/valsartan combination has been used for the treatment of heart failure with reduced ejection fraction, but in alcoholic cardiomyopathy, the primary intervention would be abstinence from alcohol. Furosemide may help relieve congestive symptoms, and spironolactone may aid in the prevention of cardiac remodeling, but using these drugs alone will not offer benefits if the patient continues consuming alcohol. Therefore, the management of alcoholic cardiomyopathy involves complete abstinence from alcohol and anti-heart failure measures.

The patient’s symptoms suggest a diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) or Churg-Strauss syndrome. EGPA is a rare systemic necrotising vasculitis that progresses through three phases, with renal involvement being common in the final phase. There is an association between the introduction of leukotriene receptor antagonists (LTRAs) and the onset of EGPA, possibly due to a subclinical form of the disease being suppressed by corticosteroids. The patient may have had aspirin-sensitive asthma, which has a therapeutic role for LTRAs and may be linked to EGPA.

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)

Eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome, is a type of small-medium vessel vasculitis that is associated with ANCA. It is characterized by asthma, blood eosinophilia (more than 10%), paranasal sinusitis, mononeuritis multiplex, and pANCA positivity in 60% of cases.

Compared to granulomatosis with polyangiitis, EGPA is more likely to have blood eosinophilia and asthma as prominent features. Additionally, leukotriene receptor antagonists may trigger the onset of the disease.

Overall, EGPA is a rare but serious condition that requires prompt diagnosis and treatment to prevent complications.

Local muscle strengthening exercises and improving general aerobic fitness are crucial for managing knee and hip osteoarthritis. In the case of this woman with chronic hip pain, acute injury is unlikely based on recent negative imaging. Therefore, as per the latest NICE guidance, she should be offered weight loss assistance and advised on local muscle strengthening exercises and general aerobic fitness. While elevating limbs can reduce acute swelling in acute injuries, it will not benefit this woman’s osteoarthritis. Similarly, reducing alcohol intake is a preventative measure for gout and not effective in this case. While regular rest throughout the day may provide temporary relief, it will not result in lasting improvement and may be debilitating.

The Role of Glucosamine in Osteoarthritis Management

Glucosamine is a natural component found in cartilage and synovial fluid. Several double-blind randomized controlled trials have reported significant short-term symptomatic benefits of glucosamine in knee osteoarthritis, including reduced joint space narrowing and improved pain scores. However, more recent studies have produced mixed results. The 2008 NICE guidelines do not recommend the use of glucosamine, and a Drug and Therapeutics Bulletin review advised against prescribing it on the NHS due to limited evidence of cost-effectiveness. Despite this, some patients may still choose to use glucosamine as a complementary therapy for osteoarthritis management. It is important for healthcare professionals to discuss the potential benefits and risks of glucosamine with their patients and to consider individual patient preferences and circumstances.

Secondary Cold Agglutinin Disease and its Causes

Secondary cold agglutinin disease is a condition that is characterized by anaemia and haemoglobinuria due to intravascular haemolysis. This condition typically occurs two to three weeks following an infection, such as with Mycoplasma pneumoniae, viruses like EBV and CMV, Legionnaires’ disease, malaria, and others. Cold agglutinins are present in the body at low titres, but in this condition, they become more prevalent and cause the destruction of red blood cells.

It is important to note that this condition is secondary to an underlying infection and is not a primary disease. The symptoms of this condition can be severe and can lead to complications if left untreated.

Management of Severe Aortic Stenosis

Severe symptomatic aortic stenosis (AS) requires prompt management to improve prognosis. Aortic valve replacement is the recommended treatment for all symptomatic patients with severe AS. However, it is important to assess for concomitant coronary artery disease (CAD) before surgery. Cardiac angiography should be performed to determine the need for revascularization at the time of surgery, in the form of coronary artery bypass grafting.

A treadmill stress test should be avoided in patients with severe AS as it may precipitate a syncopal episode. Balloon valvulotomy may be considered as a bridge to surgery in unstable patients, but surgical valve replacement is the preferred treatment option.

Before proceeding with aortic valve replacement, significant CAD should be ruled out. If present, CABG may be required at the same time as valve replacement. Starting an ACE inhibitor in a patient with severe AS risks a significant reduction in ventricular filling pressure and increases the risk of collapse.

Treatment Options for Primary Pulmonary Hypertension

Primary pulmonary hypertension is a condition characterized by high blood pressure in the pulmonary arteries. The choice of therapy depends on several factors, including positive reactivity testing and the patient’s heart rate. Calcium channel antagonists (CCB) are the initial therapy of choice for patients who are vasoreactive. Amlodipine, a non-cardioselective CCB, is preferred over diltiazem, which can cause symptomatic bradycardia. Bosentan, a dual endothelin receptor antagonist, is used for patients who are not vasoreactive or as a combination therapy for those who have not responded to high dose CCB. Iloprost, a prostacyclin analogue, and sildenafil, a selective inhibitor of phosphodiesterase type 5, are also used for non-vasoreactive patients or as combination therapy. The choice of treatment should be individualized based on the patient’s clinical presentation and response to therapy.

Bile acid malabsorption can cause watery diarrhea due to the inability of the ileum to reabsorb bile acids. This can occur in cases where the ileum is non-functioning or has been lost due to disease. Treatment for this condition involves the use of bile acid sequestrants like cholestyramine.

Pancreatic insufficiency, as seen in pancreatitis, can also lead to diarrhea. In such cases, the stool may have a foul smell and be difficult to flush due to its high fat content (steatorrhea). Pancreatin is the preferred treatment for this condition, although faecal elastase levels should be checked to rule out pancreatic insufficiency.

While loperamide can be used to treat diarrhea caused by various factors, cholestyramine is the first-line treatment for bile acid malabsorption, which is the most likely cause of the patient’s symptoms.

Although vitamin B12 deficiency is a common consequence of ileal resection, it is not likely to be the cause of the patient’s symptoms as they are not anemic. Therefore, hydroxocobalamin is not indicated.

Understanding Bile-Acid Malabsorption

Bile-acid malabsorption is a condition that can cause chronic diarrhea. It can be primary, which means that it is caused by excessive production of bile acid, or secondary, which is due to an underlying gastrointestinal disorder that reduces bile acid absorption. This condition can lead to steatorrhea and malabsorption of vitamins A, D, E, and K.

Secondary causes of bile-acid malabsorption are often seen in patients with ileal disease, such as Crohn’s disease. Other secondary causes include coeliac disease, small intestinal bacterial overgrowth, and cholecystectomy.

To diagnose bile-acid malabsorption, the test of choice is SeHCAT, which is a nuclear medicine test that uses a gamma-emitting selenium molecule in selenium homocholic acid taurine or tauroselcholic acid. Scans are done 7 days apart to assess the retention or loss of radiolabeled 75 SeHCAT.

The management of bile-acid malabsorption involves the use of bile acid sequestrants, such as cholestyramine. These medications can help to bind bile acids in the intestine, reducing their concentration and improving symptoms. With proper management, individuals with bile-acid malabsorption can experience relief from their symptoms and improve their quality of life.

Differential Diagnosis of Haematuria and Renal Failure in a Young Patient

Haematuria and renal failure in a young patient can be caused by various conditions. One possible cause is immunoglobulin A (IgA) nephropathy, which is associated with mucosal infection and can lead to renal failure and hypertension. Another potential cause is ANCA-associated vasculitis, which presents with acute renal failure and vasculitis symptoms and is treated with immunosuppression. Goodpasture’s disease, an autoimmune disorder, can also cause renal failure and alveolar haemorrhage, but a negative anti-GBM titre makes it unlikely in this case. Post-streptococcal glomerulonephritis (PSGN) is another immune complex-forming illness, but it typically occurs weeks after infection and is not associated with the degree of hypertension seen in this patient. Transitional cell carcinoma (TCC) of the bladder can cause haematuria and obstructive renal failure, but it is unlikely in a young patient with no significant history and a normal CT scan. A thorough differential diagnosis is necessary to determine the underlying cause of haematuria and renal failure in a young patient.

Understanding the Differential Diagnosis of Hyperglycaemia

Hyperglycaemia can be caused by various conditions, and it is important to differentiate between them for appropriate management. In the case of a patient with a BMI of 20 and a family history of diabetes, maturity-onset diabetes of the young (MODY) is a likely diagnosis. MODY is a genetic subtype of diabetes that presents with early onset, non-insulin-dependent diabetes and is caused by a monogenic defect affecting insulin sensing or release. It is crucial to diagnose MODY3 as patients can be managed with sulphonylurea instead of insulin.

Metabolic syndrome is another possible cause of hyperglycaemia, but given the patient’s BMI and family history, MODY is more likely. Incidental hyperglycaemia is also a consideration, but the FPG result of 12 is well into the abnormal range, and the autosomal-dominant inheritance pattern of diabetes makes MODY the more probable diagnosis.

Type-1 diabetes mellitus is unlikely as the patient does not present with symptoms such as polyuria, polydipsia, and lethargy. Similarly, type-2 diabetes mellitus is improbable given the patient’s BMI. In conclusion, understanding the differential diagnosis of hyperglycaemia is crucial for appropriate management and treatment.

Treatment for Accelerated Hypertension

Accelerated hypertension is a medical emergency that requires immediate treatment to reduce blood pressure. Clinical reviews recommend a reduction of around 25% in blood pressure during the first 24-48 hours of therapy. However, it is important to avoid targeting blood pressure reduction too aggressively, as this may result in significant end organ damage due to disordered autoregulation. The initial therapy of choice for accelerated hypertension is IV therapy with either sodium nitroprusside or labetolol. Other alternatives include phentolamine or hydralazine. It is crucial to differentiate between hypertensive emergency and urgency categories to ensure appropriate treatment. Proper management of accelerated hypertension can prevent serious complications and improve patient outcomes.

To treat a gastrointestinal MALT lymphoma, the first step is to eradicate the Helicobacter pylori (HP) infection with a regimen of antibiotics and proton pump inhibitors (PPI). This leads to remission in 75% of cases. A carbon-13 urea breath test (UBT) should be done approximately 6 weeks after eradication therapy to confirm eradication. The UBT detects the presence of urease, which is produced by HP, in the stomach. If antibiotic therapy is not successful, chemotherapy or radiotherapy may be considered depending on the stage of the disease. Duodenal stent insertion and laparoscopic resection are not initial treatment strategies. Endoscopic mucosal resection and resectional surgery are rarely needed and would only be considered after initial medical therapies have failed.

In a study published in the New England Journal of Medicine in 2001, Elkayam and colleagues reported on the outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. The study found that women with this condition who became pregnant again had both maternal and fetal complications. Specifically, some of these women had elevated levels of troponin I and an enlarged left ventricular end-diastolic diameter greater than 6cm.

Dilated cardiomyopathy (DCM) is the most common type of cardiomyopathy, accounting for 90% of cases. The cause of DCM can be idiopathic, myocarditis, ischaemic heart disease, peripartum, hypertension, iatrogenic, substance abuse, inherited, infiltrative, or nutritional. About one-third of patients with DCM are believed to have a genetic predisposition, and a variety of heterogeneous defects have been identified. The majority of defects are inherited in an autosomal dominant manner, although other patterns of inheritance are also observed. Dilated heart leading to predominantly systolic dysfunction is the pathophysiology of DCM. All four chambers are dilated, but the left ventricle is more dilated than the right ventricle. Eccentric hypertrophy, which is the addition of sarcomeres in series, is observed. The classic signs of heart failure, a systolic murmur, S3, and a balloon appearance of the heart on the chest x-ray, are common features of DCM.

The FEV1/FVC ratio is a measure used in lung function tests to assess the health of the lungs. In normal individuals, this ratio ranges from 0.75 to 0.85. If the ratio falls below 0.70, it suggests an obstructive problem that reduces the volume of air that can be expelled in one second (FEV1). However, in restrictive lung disease, the FVC is also reduced, which can result in a normal or high FEV1/FVC ratio.

It is important to understand the FEV1/FVC ratio as it can help diagnose and monitor lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. A low ratio indicates that the airways are obstructed, while a normal or high ratio suggests a restrictive lung disease. Lung function tests are often used to assess the severity of these conditions and to monitor the effectiveness of treatment. By the FEV1/FVC ratio, healthcare professionals can provide appropriate care and management for patients with lung diseases.

Polymyalgia Rheumatica/Temporal Arteritis: Symptoms and Treatment

Polymyalgia rheumatica/temporal arteritis is a condition that can cause a variety of symptoms. It may present with predominantly polymyalgia symptoms such as muscle pain and stiffness, or arteritis symptoms such as headaches, scalp tenderness, and jaw claudication. Systemic features like fever, malaise, and weight loss may also be present. Weakness is not a typical feature, but it may be apparent due to pain or stiffness with weight loss. The ESR (erythrocyte sedimentation rate) is usually very high in this condition.

Temporal arteritis is a serious complication of this condition that can result in blindness. It is important to note that temporal arteritis is a vasculitis that affects medium and large-sized arteries throughout the body, not just the temporal artery. The superficial temporal artery supplies the orbit of the eye and is a branch of the external carotid artery, while the ophthalmic artery supplies the majority of the blood to the eye itself and is a branch of the internal carotid artery. Inflammation and narrowing of the temporal artery can cause blindness.

If temporal arteritis is suspected, it must be treated with high-dose steroids. This condition is a reminder that prompt diagnosis and treatment are crucial to prevent serious complications.

Wilson’s Disease and its Diagnostic Features

Wilson’s disease is a rare genetic disorder that affects copper metabolism in the body. While ceruloplasmin levels are normal in about 5% of cases, a family history of the disease and the presence of resting, postural, cerebellar, and wing beating tremors suggest the possibility of Wilson’s disease. Additionally, proximal renal tubular acidosis type 2 may occur, but it is usually non-significant and does not require serum electrolyte testing. A slit lamp examination can detect Kayser-Fleischer corneal rings in almost all untreated cases, and the sunflower cataract may also be present.

The diagnosis of Wilson’s disease is based on serum copper, 24-hour urinary copper, and liver biopsy, which are the cornerstones of diagnosis. MRI studies have also identified focal abnormalities in the white matter, pons, and deep cerebellar nuclei. Therefore, a combination of clinical features and diagnostic tests is necessary to confirm the diagnosis of Wilson’s disease.

Intravenous immunoglobulin (IVIG) is the preferred treatment for ITP when there is a need to quickly raise platelet levels, especially in cases of life-threatening bleeding. The expected response time is 1-3 days, and platelets may also be given in addition. Prednisolone is the typical first-line treatment for ITP, but it takes longer to raise platelet levels (4-14 days) and may not be effective in emergency situations. Rituximab is used in refractory cases and takes longer to work (7-56 days), while azathioprine is a steroid-sparing agent that takes even longer (30-90 days) to take effect. Romiplostim is a fusion protein that increases platelet production and takes 5-14 days to raise platelet levels.

Immune Thrombocytopenia (ITP) in Adults: Symptoms, Diagnosis, and Treatment

Immune thrombocytopenia (ITP) is a condition where the immune system attacks platelets, leading to a reduction in their count. This condition is more common in older females and tends to be chronic in adults. Symptoms may include petechiae, purpura, and bleeding, but catastrophic bleeding is not a common presentation. ITP is usually detected incidentally during routine blood tests.

Diagnosis of ITP is based on a full blood count, which shows isolated thrombocytopenia, and a blood film. A bone marrow examination is no longer routinely used, and antiplatelet antibody testing has poor sensitivity and does not affect clinical management.

The first-line treatment for ITP is oral prednisolone, which is effective in most cases. Pooled normal human immunoglobulin (IVIG) may also be used, especially if active bleeding or an urgent invasive procedure is required. IVIG raises the platelet count quicker than steroids. Splenectomy, which used to be a common treatment for ITP, is now less commonly used.

In some cases, ITP may be associated with autoimmune haemolytic anaemia (AIHA), a condition known as Evan’s syndrome. In such cases, treatment may involve addressing both conditions simultaneously.

Neutropenia in Rheumatoid Arthritis Patients

Patients with rheumatoid arthritis (RA) often experience neutropenia, which is a condition characterized by a low count of neutrophils in the blood. This can be caused by drug-related factors, which typically improve over time, or by Felty’s syndrome, a condition that involves splenomegaly and pancytopenia, with neutropenia being the predominant symptom. While rheumatoid vasculitis is rare, it can present with a vasculitic rash, neuropathy, and high inflammatory markers. In some cases, RA may coexist with systemic lupus erythematosus (SLE), which is known as rhupus. However, if a patient is ANA negative, it is unlikely that they have SLE.

Possible Causes of Chronic Vestibular Dysfunction

Chronic vestibular dysfunction can have various causes, and it is essential to identify the underlying condition to provide appropriate treatment. In this case, the patient has spent a considerable amount of time in the intensive therapy unit and may have been treated with vancomycin, which can cause toxicity. Vancomycin toxicity primarily manifests as tinnitus, but other vestibular symptoms, including dizziness, may also occur. Adequate testing of vancomycin levels is crucial to avoid toxicity.

A vestibular stroke without other neurological signs is highly unlikely to be the cause of chronic vestibular dysfunction. Furosemide toxicity is more commonly associated with hearing loss, and aspirin toxicity is associated with acute tinnitus in the first few hours after overdose. Viral neuronitis is also a possible cause, but given the history of exposure to vancomycin, it is much more likely to be vancomycin toxicity. Therefore, identifying the underlying cause of chronic vestibular dysfunction is crucial to provide appropriate treatment and improve the patient’s quality of life.

In addition to the aforementioned effects, an overdose of citalopram may also cause nausea, vomiting, tremors, nystagmus, and convulsions. If convulsions occur, benzodiazepines can be used to manage them. Treatment for SSRI poisoning is typically supportive in nature. For more information, please refer to the BNF.

Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression, with citalopram and fluoxetine being the preferred options. They should be used with caution in children and adolescents, and patients should be monitored for increased anxiety and agitation. Gastrointestinal symptoms are the most common side-effect, and there is an increased risk of gastrointestinal bleeding. Citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in certain patients. SSRIs have a higher propensity for drug interactions, and patients should be reviewed after 2 weeks of treatment. When stopping a SSRI, the dose should be gradually reduced over a 4 week period. Use of SSRIs during pregnancy should be weighed against the risks and benefits.

Hyper IgM syndrome is a rare immunodeficiency disorder that is inherited through the X-linked pattern. It is characterized by recurrent infections, such as Pneumocystis pneumonia, hepatitis, and diarrhea, and typically presents in infancy. Definitive diagnosis requires flow cytometry or molecular genetic testing. Patients with neutropenia and reduced IgG and IgA levels, but normal or elevated IgM levels, are highly suggestive of this diagnosis.

Chediak-Higashi syndrome also presents with recurrent infections, but the pathogens are more common, with recurrent Staphylococcus aureus being the most frequent. Other symptoms include albinism, photophobia, and peripheral neuropathy during teenage years.

Selective IgA deficiency patients are usually asymptomatic, but they may experience recurrent sinopulmonary and gastrointestinal infections. However, this diagnosis is unlikely in this case due to low IgG levels, as selective IgA deficiency typically has normal IgG levels.

Brunton’s agammaglobulinemia also presents with recurrent bacterial infections, but all immunoglobulin levels are generally reduced. Genetic testing for mutations within the BTK gene is the definitive diagnostic test.

Overview of Primary Immunodeficiency Disorders

Primary immunodeficiency disorders are conditions that affect the immune system’s ability to fight off infections and diseases. These disorders can be classified based on which component of the immune system is affected. Neutrophil disorders, for example, are caused by a lack of NADPH oxidase, which reduces the ability of phagocytes to produce reactive oxygen species. This leads to recurrent pneumonias and abscesses, particularly due to catalase-positive bacteria and fungi. B-cell disorders, on the other hand, are caused by defects in B cell development, resulting in low antibody levels and recurrent infections. T-cell disorders are caused by defects in T cell development, leading to recurrent viral and fungal diseases. Finally, combined B- and T-cell disorders are caused by defects in both B and T cell development, resulting in recurrent infections and an increased risk of malignancy. Understanding the underlying defects and symptoms of these disorders is crucial for proper diagnosis and treatment.

The patient’s symptoms, including choreiform movements, rigidity, eye movement abnormalities, and cognitive problems, strongly suggest Huntington’s disease (HD). HD is a trinucleotide repeat disorder that affects the huntingtin gene on chromosome 4. Genetic anticipation is observed in HD, where successive generations tend to show an earlier onset of a more severe phenotype due to expansion of the repeat length. There is currently no cure for HD, and patients who are at risk but asymptomatic can choose to undergo predictive testing after undergoing genetic counseling. Other rare causes of adult-onset movement disorders, such as neuroacanthocytosis and genetic prion disease, should also be considered. Tests for Wilson’s disease are unlikely to be necessary due to the presence of an autosomal dominant mode of inheritance. A single gene test for HD is recommended over a next-generation gene chip for Parkinson’s disease, as the clinical features are not compatible with Parkinson’s.

The short synacthen test was performed on a patient with symptoms of adrenal failure. A cortisol level of >420 nmol/L at 30 or 60 minutes post-synacthen is considered an adequate adrenal response. However, the patient’s test showed a borderline response, which makes primary adrenal failure less likely but does not rule out secondary adrenal failure. Further investigation is necessary when results are borderline and there is a strong clinical history. Secondary adrenal insufficiency presents similarly to Addison’s disease but without hypovolaemia and pigmentation.

To distinguish Addison’s disease from secondary causes of adrenal insufficiency, such as steroid use, panhypopituitarism, and isolated failure of adrenocorticotropic hormone (ACTH), a long synacthen test is used. This test involves taking samples at 1, 4, 8, and 24 hours.

The insulin tolerance test is the gold standard for assessing the hypothalamic-pituitary-adrenal axis but is dangerous and contraindicated in certain patients. The oral glucose tolerance test is used to diagnose diabetes, insulin resistance, impaired beta-cell function, and acromegaly when used with IGF-1 levels. The overnight dexamethasone suppression test is useful in identifying adrenal hyperfunction or failure but is unlikely to be useful after a negative short synacthen test, which is the gold standard for diagnosing Addison’s disease. The water deprivation test is used to diagnose diabetes insipidus.

Investigating Addison’s Disease: ACTH Stimulation Test and Serum Cortisol Levels

When investigating a patient suspected of having Addison’s disease, the most definitive test is the ACTH stimulation test, also known as the short Synacthen test. This involves measuring plasma cortisol levels before and 30 minutes after administering Synacthen 250 ug IM. Adrenal autoantibodies, such as anti-21-hydroxylase, may also be detected.

However, if an ACTH stimulation test is not readily available, a 9 am serum cortisol level can be useful. A level of over 500 nmol/l makes Addison’s disease very unlikely, while a level below 100 nmol/l is definitely abnormal. If the level falls between 100-500 nmol/l, an ACTH stimulation test should be performed.

It is important to note that around one-third of undiagnosed patients with Addison’s disease may also have associated electrolyte abnormalities, such as hyperkalaemia, hyponatraemia, hypoglycaemia, and metabolic acidosis. Therefore, it is crucial to investigate these levels as well to ensure a proper diagnosis and treatment plan.

Tick-borne encephalitis is suspected in this patient based on their history and symptoms. This disease is caused by a flavivirus infection of the central nervous system, transmitted by the Ixodes tick. It typically presents as meningoencephalitis and has a biphasic course. Diagnosis is confirmed by serology for TBE-specific antibodies. Treatment is supportive, and aciclovir may be given initially as an empirical treatment but can be stopped when HSV/VZV is ruled out.

In this case, the patient’s CSF and other investigations support the diagnosis of TBE. While doxycycline initially appeared to help, this is likely due to the symptom-free interval seen in TBE rather than any effect on the underlying disease. Lyme disease is unlikely based on negative serology for Borrelia burgdorferi, so another course of doxycycline is not appropriate. Continuing aciclovir is not necessary given negative CSF investigations for HSV-1, HSV-2, and VZV. IV immunoglobulin is not indicated based on the available information.

Tick-borne Encephalitis: A Viral Infection Transmitted by Ticks

Tick-borne encephalitis is a viral infection caused by the Flavivirus and transmitted by ticks that are hosted by native wildlife. The virus is transmitted to the host through the bite of an infected tick. The infection manifests as a biphasic illness, with the first phase characterized by constitutional upset, including headaches, myalgia, and fevers. This is followed by an asymptomatic period before the disease progresses to phase two, which is characterized by symptoms of central nervous system involvement, such as meningitis or encephalitis. The incubation period can be up to a month, and long-term neurological sequelae may persist for months to years following infection.

There are three species of flavivirus implicated in tick-borne encephalitis: European, Far Eastern, and Siberian. The Far Eastern species typically causes the most severe illness, often progressing rapidly to central nervous system involvement with no asymptomatic period. Diagnosis is made on the basis of clinical suspicion, with confirmation via cerebrospinal fluid (CSF) analysis demonstrating specific IgM or IgG antibodies. Treatment is supportive, with the addition of doxycycline or a cephalosporin advised if Lyme disease is considered a differential diagnosis until confirmation via CSF sampling can be obtained.

A vaccination is available and recommended for those travelling to endemic areas and planning to engage in high-risk outdoor activities, such as hiking in rural forested areas and/or grasslands. Precautions to avoid tick bites are recommended to all travellers to endemic areas.